doctor head
 
  pharmacy and drugs  
search Search
 
       About us       News      A-Z Drugs      Stores      Top Drugs      Contact  
  doctor doctor hand
 
  doctor legs  
 
 
 
 

  Diseases

  Newsletter
Subscribe to our newsletter:
Name:
E-mail:
    Search results
Search results for: symb

1 - 5 of 11 <<previous | next>>

Diseases results:

Acute promyelocytic leukemia

Articles results:

Callisto Pharmaceuticals Announces Publication Of Research Articles On Atiprimod Preclinical Studies In Myeloid And Other Malignancies
Callisto Pharmaceuticals, Inc.


Announcing Clinical Therapeutics Journal Club - An Innovative Online Forum
Excerpta Medica announces the launch of Clinical Therapeutics Journal Club (CTJournalClub.com)-an innovative online resource offering the latest in pharmaceutical progress. Medical professionals can now keep pace with important clinical developments through the original research reports and expert reviews provided at http://ctjournalclub.com/.


Containment Technologies Group, Inc. Introduces New Aseptic Hospital Isolator Technology
Containment Technologies Group, Inc. announces a new advanced aseptic compounding isolator for pharmacy-compounded sterile preparations. The Mobile Isolation Chamber-Environmental Decontamination Unit (MIC-EDU) utilizes Vaprox(R) Hydrogen Peroxide Sterilant to treat the exterior of components before they are placed in hospital ISO Class 5 environments for compounding.


Wiley Acquires HEED, The World's Leading Health Economic Evaluations Database
John Wiley & Sons, Ltd., announced on 15-Nov-2006 that it has completed the acquisition of Health Economic Evaluations Database (HEED), an online source of health economic information and evaluations.HEED was developed as a joint initiative between the Office of Health Economics (OHE) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA).


The EU Regulation On Paediatric Medicines Adopted On 12 December 2006, Enters Into Force On 26 January 2007
Content of final RegulationThe Regulation aims to establish a legislative framework that will fulfil the following main objectives:-- increased availability of medicines specifically adapted and licensed for use in the paediatric population-- increased information available to the patient/carer and prescriber about the use of medicines in children, including clinical trial data-- increase in high quality research into medicines for children.




1 - 5 of 11 <<previous | next>>

© 2006-2010 pharmacy-and-drugs.com. All rights reserved.